Literature DB >> 16389417

Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA.

Carlos D'Aparecida dos Santos Machado Filho1, Fernando Augusto Almeida, Rodrigo Sestito Proto, Gilles Landman.   

Abstract

CONTEXT AND
OBJECTIVE: Recent studies have indicated that vitiligo areas contain inactive or dormant melanocytes. Melanin synthesis is related to tyrosinase presence and indicative of active metabolic state. The aim of this study was to compare repigmentation, epidermal melanocyte distribution and tyrosinase mRNA detection through reverse transcriptase polymerase chain reaction, in tissue samples of vitiligo, before and after curettage, with or without subsequent autologous skin graft using a new method. DESIGN AND
SETTING: Prospective, in the Department of Dermatology, Faculdade de Medicina do ABC, Santo André.
METHODS: Two vitiligo areas were curetted. One subsequently received grafted normal sacral autologous skin, whereas the other had no further treatment. The curetted areas were examined after 30 days, to evaluate the degree of repigmentation. The melanocyte percentages and tyrosinase mRNA presence in normal skin and vitiligo areas, before and after curettage and grafting, were compared.
RESULTS: Complete repigmentation was seen in all grafted areas, whereas non-grafted curetted vitiligo presented partial repigmentation. The melanocyte percentage in grafted areas was greater than in non-treated vitiligo skin (p = 0.01) and skin with curettage alone (p = 0.015). Tyrosinase mRNA was negative in 93.75% of non-treated vitiligo areas. After treatment (curettage alone or curettage and grafting), all lesions became positive for tyrosinase mRNA.
CONCLUSION: Metabolically inactive or dormant melanocytes are probably present within vitiligo areas, and may be activated by exogenous or endogenous stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16389417     DOI: 10.1590/s1516-31802005000400006

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases.

Authors:  Mariana Gontijo Ramos; Daniel Gontijo Ramos; Gabriel Gontijo; Camila Gontijo Ramos; Tania Nely Rocha; Rafael Henrique Rocha
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.

Authors:  Yulong Li; Min Yang; Rui Zhang; Wan Liu; Kuo Zhang; Wei Wen; Lang Yi; Qiaoxian Wang; Mingju Hao; Hui Yang; Jianmin Chang; Jinming Li
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 3.  Surgical Treatment of Vitiligo.

Authors:  Alicja Frączek; Marta Kasprowicz-Furmańczyk; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

4.  Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo.

Authors:  Carlos D' Apparecida Santos Machado Filho; Fabio Roismann Timoner
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

5.  Comparative Evaluation of Efficacy of Non-cultured Epidermal Cell Suspension and Epidermal Curettage in Stable Vitiligo.

Authors:  Shashank Tyagi; Suresh K Malhotra; Tejinder Kaur
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

6.  Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.

Authors:  Clarissa Luiza Dalla Bernardina Carvalho; Luciena Cegatto Martins Ortigosa
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.